ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2024

A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer.

Neeta Pandit-Taskar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.